Rivolo, S., Fusco, M. D., Polanco, C., Kang, A., Dhanda, D., Savone, M., . . . Soto, J. (2021). Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Rivolo, Simone, Manuela Di Fusco, Carlos Polanco, Amiee Kang, Devender Dhanda, Mirko Savone, Aristeidis Skandamis, Thitima Kongnakorn, y Javier Soto. Cost-effectiveness Analysis of Apixaban Versus Vitamin K Antagonists for Antithrombotic Therapy in Patients with Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Spain. Public Library of Science (PLoS), 2021.
Cita MLA (8a ed.)Rivolo, Simone, et al. Cost-effectiveness Analysis of Apixaban Versus Vitamin K Antagonists for Antithrombotic Therapy in Patients with Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Spain. Public Library of Science (PLoS), 2021.